Literature DB >> 2189006

Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms.

E Heikkilä1, A Siitonen, M Jahkola, M Fling, L Sundström, P Huovinen.   

Abstract

Trimethoprim (TMP) resistance among Shigella species isolated from Finnish travelers increased from 3.0% in 1975-1982 to 42.0%-43.8% in 1987-1988. Of the 317 TMP-resistant Shigella isolates identified during 1975-1988, 175 (55%) collected in 1985-1987 and in 1988 were tested further. Almost all (98%) were highly resistant to TMP, suggesting a plasmid-mediated origin. The type I dihydrofolate reductase (DHFR) gene was detected in 85% of the isolates studied. Twenty-three percent of the type I DHFR-positive isolates failed to hybridize with a probe detecting only Tn7-derived sequences, suggesting that the type I DHFR gene may occur independently of transposon Tn7. Four of the five Shigella species isolated from travelers to Sri Lanka hybridized with the probe for type V DHFR gene, implying a local distribution of the type V DHFR gene. The type II and type III DHFR genes were not found among the isolates studied. Only 12% of the TMP-resistant Shigella isolates failed to hybridize with any of the DHFR gene probes used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189006     DOI: 10.1093/infdis/161.6.1242

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers.

Authors:  K Haukka; A Siitonen
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

3.  Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers.

Authors:  Nadav Orr; David E Katz; Jacob Atsmon; Paull Radu; Miri Yavzori; Tamar Halperin; Tamar Sela; Raid Kayouf; Zivit Klein; Ruhama Ambar; Dani Cohen; Marcia K Wolf; Malabi M Venkatesan; Thomas L Hale
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 5.  Quinolones in the treatment of acute bacterial diarrhoeal diseases.

Authors:  H E Akalin
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.

Authors:  A A Lima; N L Lima; M C Pinho; E A Barros Juñior; M J Teixeira; M C Martins; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element.

Authors:  E Heikkilä; M Skurnik; L Sundström; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Appearance of a new trimethoprim resistance gene, dhfrIX, in Escherichia coli from swine.

Authors:  C Jansson; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

9.  Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland.

Authors:  E Heikkilä; L Sundström; M Skurnik; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

10.  Prevalence of Shigella serogroups and their antimicrobial resistance patterns in southern Trinidad.

Authors:  Fitzroy A Orrett
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.